Hereafter I will tell the complaints of patient. You have to guide me what to do next and treatment
Tooth pain, tooth decay 48 yr male
| Condition | Key Feature |
|---|---|
| Reversible Pulpitis (most likely) | Pain triggered by cold/heat, resolves in seconds |
| Irreversible Pulpitis | Pain lasts minutes-hours, may be spontaneous |
| Periapical Abscess | Pain on percussion, swelling, fever |
| Cracked Tooth Syndrome | Sharp pain on biting that resolves when chewing stops |
| Periradicular Periodontitis | Pain in tissues around root apex |
| Maxillary Sinusitis | Referred upper posterior tooth pain |
| Trigeminal Neuralgia | Lancinating pain, not related to temperature |
| TMJ Disorder | Pain on jaw movement, clicking |
| Drug | Dose | Notes |
|---|---|---|
| Ibuprofen (NSAID - first choice) | 400-600 mg every 6-8 hours with food | Scheduled dosing more effective than as-needed |
| Paracetamol (Acetaminophen) | 500-1000 mg every 6-8 hours | Can combine with ibuprofen for better effect |
| Local Anesthetic (if in dental/ED setting) | Supraperiosteal infiltration: 1-2 mL of 2% lidocaine through mucobuccal fold | Apply 20% benzocaine topically first; inferior alveolar nerve block for lower teeth |
Note: Avoid opioids for routine dental pain. NSAIDs are preferred by the American Dental Association as they offer better pain reduction with fewer harms. - Tintinalli's Emergency Medicine, p. 1622
| Stage | Definitive Treatment |
|---|---|
| Early caries (enamel/dentin, no pulp involvement) | Dental filling / restoration |
| Reversible pulpitis | Removal of caries + restoration |
| Irreversible pulpitis | Root canal treatment (RCT / endodontic therapy) |
| Pulpal necrosis / periapical abscess | Root canal OR tooth extraction |
| Cracked tooth | Dental referral - crown or extraction depending on severity |
complaint of heavy menstrual bleeding for 8 months Scan shows mild bulky uterus bilateral mild pcom
First, establish age and reproductive status - "A female patient" - assume reproductive age (not stated, please clarify if perimenopausal as management differs significantly).
| Category | Condition | Clinical Clue in This Patient |
|---|---|---|
| P - Polyp | Endometrial / cervical polyp | Common cause of HMB; needs hysteroscopy to exclude |
| A - Adenomyosis | Endometrial glands in myometrium | Bulky uterus on scan - strongly suggests this |
| L - Leiomyoma | Uterine fibroids | Bulky uterus; but no fibroid mentioned on scan |
| M - Malignancy | Endometrial carcinoma | Must exclude, especially if >45 yrs |
| C - Coagulopathy | Von Willebrand, thrombocytopenia | Ask about bruising/bleeding elsewhere |
| O - Ovulatory dysfunction | PCOS, hypothyroidism | Bilateral PCOM on scan - likely contributing |
| E - Endometrial | Primary endometrial disorder | Diagnosis of exclusion |
| I - Iatrogenic | Anticoagulants, IUD | Drug history |
| N - Not classified | Rare causes | - |
| Test | Reason |
|---|---|
| Urine pregnancy test | Always rule out pregnancy first |
| Blood pressure, pulse | Assess haemodynamic stability |
| Test | Reason |
|---|---|
| CBC / Full blood count | Anaemia from chronic blood loss (HMB x 8 months) |
| Serum ferritin + iron studies | Iron deficiency even before frank anaemia |
| TSH | Hypothyroidism causes HMB and anovulation |
| Serum prolactin | Hyperprolactinaemia causes anovulation |
| LH, FSH, LH:FSH ratio | LH:FSH >2 supports PCOS |
| Serum testosterone, DHEAS | Hyperandrogenism workup (PCOS) |
| Fasting glucose + insulin | Insulin resistance in PCOS |
| Coagulation screen (PT, APTT) | Rule out coagulopathy |
| Serum oestrogen, progesterone | Assess ovulatory status |
| Test | Reason |
|---|---|
| Transvaginal USG (if not done) | Better than transabdominal for endometrial thickness, polyps, fibroid characterisation |
| Endometrial thickness measurement | >12 mm in premenopausal or >4 mm postmenopausal warrants biopsy |
| Saline infusion sonography (SIS) | Better delineation of submucosal pathology |
| Test | Reason |
|---|---|
| Endometrial biopsy (Pipelle) | Mandatory to rule out endometrial hyperplasia / carcinoma (esp. if PCOS with chronic anovulation) |
| Hysteroscopy + D&C | Gold standard if biopsy inconclusive or polyp/fibroid suspected |
| Pap smear / cervical cytology | If not done recently |
| Drug | Dose | Notes |
|---|---|---|
| Tranexamic acid (antifibrinolytic) | 500-1000 mg TDS during heavy days | Reduces blood loss by 40-50%; first-line non-hormonal |
| NSAIDs (e.g., mefenamic acid) | 500 mg TDS during menstruation | Helps if dysmenorrhoea also present |
| Drug | Dose | Notes |
|---|---|---|
| Combined Oral Contraceptive Pill (COCP) | 1 tablet daily cyclically or continuously | Regulates cycles, reduces bleeding; also addresses PCOS features (acne, hirsutism) |
| Cyclic progestin (Norethisterone / MPA) | Norethisterone 5 mg BD-TDS, days 5-25; or MPA 10 mg/day for 10-13 days/month | Prevents endometrial hyperplasia in anovulatory PCOS; good if COCP contraindicated |
| Levonorgestrel IUD (Mirena) | Intrauterine device, lasts 5 years | First-line for HMB if contraception also desired; reduces bleeding by >90% |
| GnRH agonists (e.g., leuprolide) | Monthly depot injection | Short-term use (6 months); for severe adenomyosis before surgery |
For this patient specifically: Given bulky uterus (adenomyosis) + bilateral PCOM, a Levonorgestrel IUD or COCP is an excellent dual-action choice. Add tranexamic acid for acute heavy days. Cyclic progestins protect endometrium from hyperplasia in PCOS.
| Procedure | Indication |
|---|---|
| Endometrial ablation | HMB refractory to medical treatment; no future fertility desired |
| Myomectomy / Hysteroscopic resection | If fibroid or polyp found on hysteroscopy |
| Hysterectomy | Definitive treatment for adenomyosis; no fertility desire, failed all medical options |
Age 17 years
At age 17, the hypothalamic-pituitary-ovarian (HPO) axis is still maturing. It is normal for cycles to be anovulatory for up to 18 months after menarche. Anovulatory cycles are the most common cause of HMB in adolescents. - Textbook of Family Medicine
In adolescents, structural causes (adenomyosis, fibroids) are much rarer than in older women. COEIN causes (Coagulopathy, Ovulatory dysfunction) are far more likely. - Berek & Novak's Gynecology
| Priority | Condition | Why Consider |
|---|---|---|
| ⭐ Most likely | Anovulatory bleeding (immature HPO axis) | Age 17, irregular cycles, PCOM on scan |
| ⭐ Must not miss | Von Willebrand Disease / Coagulopathy | Up to 24% of adolescents with HMB; easy to miss |
| ⭐ Likely | PCOS | Bilateral PCOM + anovulation + age |
| Consider | Hypothyroidism | Common in this age group; causes anovulation + HMB |
| Consider | Hyperprolactinaemia | Anovulation + irregular cycles |
| Consider | Adenomyosis | Possible cause of bulky uterus (though less common at 17) |
| Rare at this age | Structural: fibroids, polyps, malignancy | Adenomyosis rare; malignancy extremely rare at 17 |
| Rule out | Pregnancy / miscarriage | Always first |
| Test | Purpose |
|---|---|
| Urine pregnancy test | Rule out pregnancy - always first |
| CBC / Full blood count | Anaemia assessment; thrombocytopenia (ITP) |
| Serum ferritin + iron studies | Iron deficiency anaemia from chronic blood loss |
| Coagulation screen: PT, APTT, bleeding time | Coagulopathy |
| Von Willebrand factor antigen + activity (ristocetin cofactor) | VWD is commonest inherited bleeding disorder; must screen in adolescents |
| Blood group and screen | If significant anaemia or bleeding |
| Test | Purpose |
|---|---|
| TSH | Hypothyroidism |
| Serum prolactin | Hyperprolactinaemia |
| LH, FSH (day 2-3 of cycle) | LH:FSH ratio >2 supports PCOS |
| Free/total testosterone, DHEAS | Hyperandrogenism |
| Fasting glucose + fasting insulin | Insulin resistance |
| 17-OH progesterone | Rule out congenital adrenal hyperplasia |
| Test | Notes |
|---|---|
| Transabdominal pelvic USG | Preferred in adolescents (non-sexually active); assess uterine size, endometrial thickness, ovarian morphology - already done |
| Transvaginal USG | Only if sexually active and better detail needed |
Note on "Bilateral PCOM" in a 17-year-old: PCOM (polycystic ovarian morphology) on ultrasound alone is NOT sufficient to diagnose PCOS in adolescents. Multifollicular ovaries are a normal finding in puberty. PCOS diagnosis in adolescents requires both irregular cycles AND clinical/biochemical hyperandrogenism - not just scan findings. - Rotterdam criteria modified for adolescents
| Drug | Dose | Notes |
|---|---|---|
| Tranexamic acid | 500-1000 mg TDS for 3-5 days during heavy flow | Reduces blood loss ~40-50%; safe in adolescents; first choice non-hormonal |
| Mefenamic acid (NSAID) | 500 mg TDS during menstruation | Reduces blood loss + helps dysmenorrhoea |
| Drug | Dose | Notes |
|---|---|---|
| Combined OCP (COCP) | 1 tablet daily (e.g., Ethinyloestradiol 30 mcg + Levonorgestrel) | First-line hormonal therapy for adolescents; regulates cycles, reduces bleeding, treats acne/hirsutism if PCOS; continue 3-6 cycles |
| Cyclic progestin (if COCP not acceptable) | Norethisterone 5 mg BD from day 14-26 of cycle; or MPA 10 mg/day for 10-13 days/month | Prevents endometrial buildup from chronic anovulation; especially useful if parents object to COCP |
Emphasize to patient and parents: hormonal therapy is being used to regulate the menstrual cycle and treat heavy bleeding - not as contraception. Reassure about safety of low-dose preparations.
| Priority | Action |
|---|---|
| 1 | Urine pregnancy test |
| 2 | CBC, ferritin, coagulation screen, VWD screen |
| 3 | TSH, prolactin, LH/FSH, testosterone |
| 4 | Start tranexamic acid during heavy days |
| 5 | Start COCP or cyclic norethisterone for cycle regulation |
| 6 | Iron supplementation |
| 7 | Reassess PCOS diagnosis formally after age 18 |
| 8 | Adolescent gynaecology referral |
Weight 46 kg
| Height | BMI at 46 kg | Classification |
|---|---|---|
| 150 cm | 20.4 | Low-normal |
| 155 cm | 19.1 | Low-normal |
| 160 cm | 18.0 | Borderline underweight |
| 165 cm | 16.9 | Underweight |
| Rank | Diagnosis | Why |
|---|---|---|
| ⭐1 | Anovulatory bleeding - immature HPO axis | Age 17, lean weight, normal for 18 months post-menarche |
| ⭐2 | Hypothalamic dysfunction from low weight / nutritional deficit | Weight 46 kg; fat mass critical for oestrogen production |
| ⭐3 | Von Willebrand Disease / Coagulopathy | Must not miss - 24% of teens with HMB |
| 4 | Lean PCOS | Bilateral PCOM + anovulation - but confirm after 18 |
| 5 | Hypothyroidism | Common cause of HMB + weight issues in teen girls |
| 6 | Eating disorder (Anorexia/Bulimia) | Screens positive if weight low + dietary restriction |
| 7 | Adenomyosis | Possible but unlikely at 17 with low weight |
| Test | Purpose |
|---|---|
| Height measurement | Calculate exact BMI |
| Serum FSH, LH | Low in hypothalamic anovulation; elevated FSH = primary ovarian failure |
| Serum oestradiol (E2) | Low oestrogen in hypothalamic suppression; important for bone health |
| TSH + free T4 | Hypothyroidism very common in this profile |
| Prolactin | Elevated prolactin causes anovulation |
| Serum albumin, total protein | Nutritional status assessment |
| Vitamin D + Calcium | Chronic low weight = bone density risk; oestrogen deficiency worsens this |
| DEXA scan (if low oestrogen confirmed) | Bone mineral density - low oestrogen at this age = serious long-term bone risk |
| Serum glucose + insulin | Even lean PCOS has insulin resistance |
| Drug | Dose | Notes |
|---|---|---|
| Tranexamic acid | 500 mg TDS during heavy days (3-5 days) | Safe; reduces blood loss ~40-50%; does not suppress HPO axis |
| Mefenamic acid | 250-500 mg TDS during menstruation | Additional 25% reduction in blood loss |
| Option | Dose | Notes |
|---|---|---|
| COCP (low dose) | EE 20-30 mcg + progestin daily | Regulates cycles; BUT if hypothalamic suppression is the cause, COCP may mask the underlying problem and delay diagnosis. Discuss risk vs benefit. |
| Cyclic progestin | Norethisterone 5 mg BD day 14-26 | Protects endometrium; less suppressive than COCP |
Important: If the cause is hypothalamic dysfunction from low weight, oestrogen levels are already LOW. Starting a low-dose COCP is reasonable to protect bone density AND regulate cycles. However, the primary treatment must remain nutritional rehabilitation - not just hormonal suppression of the HPO axis.
| Referral | Reason |
|---|---|
| Paediatric / Adolescent Gynaecology | HMB management, PCOM assessment |
| Dietitian / Nutritionist | Nutritional rehabilitation |
| Haematology | If VWD / coagulopathy screen positive |
| Endocrinology | If thyroid, prolactin, or adrenal abnormality found |
| Child & Adolescent Psychiatry (CAMHS) | If eating disorder suspected |
| Parameter | Finding | Action |
|---|---|---|
| Age 17 | Immature HPO axis | Reassurance + time; avoid over-medicating |
| Weight 46 kg | Likely low/borderline underweight | Nutritional assessment; weight gain |
| HMB x 8 months | Chronic blood loss | Iron supplementation; tranexamic acid |
| Bilateral PCOM | Not diagnostic of PCOS alone at this age | Recheck at 18 with clinical criteria |
| Bulky uterus | Likely adenomyosis vs normal variant | Low suspicion at 17; monitor |
| Possible anaemia | 8 months HMB | CBC + ferritin urgently |
| Coagulopathy risk | 24% of adolescents with HMB | VWD screen mandatory |
This patient came with complaints of pus discharge 3 days Fever 3 days intermittent
| Detail | Finding |
|---|---|
| Name | Chandiraselvi |
| Age | 57 years, Female |
| Procedure done | Vaginal Hysterectomy + Pelvic Floor Repair |
| Original diagnosis | PL2, Prior 2 NVD, Rectocele, Stage III-IV Prolapse |
| Comorbidities | Hypertension (known), AKI - Recovered |
| Discharge Hb | 9.6 g/dL (mild anaemia) |
| Creatinine at discharge | 1.4 mg/dL (borderline elevated - post AKI) |
| Now presenting | Pus discharge x 3 days + Intermittent fever x 3 days |
| Parameter | What to check |
|---|---|
| Temperature | >38°C = febrile; >39°C = high fever |
| Pulse | Tachycardia (>100) = sign of sepsis |
| Blood pressure | Hypotension = septic shock; also monitor as she has SHTN |
| SpO2 | Baseline |
| RR | Tachypnoea = sepsis |
| Diagnosis | Likelihood | Clinical Clue |
|---|---|---|
| Vaginal vault infection / cuff cellulitis | ⭐⭐⭐ Very likely | Most common post-hysterectomy complication; fever + pus discharge from vault |
| Vaginal vault haematoma (infected) | ⭐⭐⭐ Likely | Haematoma forms post-op; becomes infected = fever + discharge |
| Pelvic abscess | ⭐⭐ Possible | Pelvic pain + fever + mass on bimanual; more severe systemic signs |
| Surgical site infection (perineal/pelvic floor repair) | ⭐⭐ Possible | If pus coming from perineal repair site |
| Urinary tract infection | ⭐ Consider | Post-hysterectomy urethral/bladder trauma; dysuria + fever |
| Vesico-vaginal / recto-vaginal fistula | ⭐ Must exclude | Watery/faeculent discharge through vagina post-op |
| Peritonitis / bowel injury | Urgent if signs present | Abdominal rigidity, rebound tenderness |
| Test | Purpose |
|---|---|
| Temperature, Pulse, BP, SpO2 | Sepsis assessment |
| Speculum exam | Identify source of pus - vault vs wound |
| High vaginal swab (HVS) for culture & sensitivity | Identify organism; guide antibiotic therapy |
| Wound swab | If perineal/wound site also discharging |
| Test | Purpose |
|---|---|
| CBC | WBC: leukocytosis indicates infection; Hb: monitor anaemia (was 9.6 at discharge) |
| CRP / ESR | Inflammatory marker - severity of infection |
| Blood cultures x 2 | If high fever with rigors (rule out bacteraemia/sepsis) |
| Serum creatinine + urea | She had AKI that "recovered" - reassess renal function before prescribing nephrotoxic antibiotics |
| Blood glucose | Hyperglycaemia impairs wound healing / increases infection risk |
| Serum electrolytes | Na was 136, K 4.4 at discharge - recheck |
| Test | Purpose |
|---|---|
| Pelvic USG (transvaginal if possible) | Look for vault haematoma, pelvic abscess, fluid collection |
| CT abdomen & pelvis (with contrast) | If pelvic abscess suspected or systemic sepsis signs; guides drainage planning |
| Test | Purpose |
|---|---|
| Urine routine + microscopy | Rule out UTI (common post-pelvic surgery) |
| Urine culture | If UTI suspected |
| Severity | Regimen |
|---|---|
| Mild - Outpatient | Cap Amoxicillin-Clavulanate 625 mg TDS x 7 days + Metronidazole 400 mg TDS x 7 days |
| Moderate - Oral escalation | Tab Ciprofloxacin 500 mg BD + Metronidazole 400 mg TDS x 7-10 days |
| Severe - Admit + IV | Inj Cefotaxime 1g IV BD (or Ceftriaxone 2g IV OD) + Inj Metronidazole 500 mg IV TDS |
| Penicillin allergy | Clindamycin 600 mg IV TDS + Gentamicin (use with CAUTION - she had AKI; check creatinine first) |
⚠️ Critical note on Gentamicin / Aminoglycosides: She had AKI (recovered) - creatinine at discharge was 1.4. Avoid nephrotoxic antibiotics until renal function is reassessed. Prefer cephalosporin + metronidazole combination.
Culture-guided therapy: Start empirical antibiotics, then de-escalate or adjust based on HVS culture & sensitivity results (usually available in 48-72 hours).
| Treatment | Dose | Notes |
|---|---|---|
| Paracetamol | 500-1000 mg TDS | Antipyretic + analgesic; she received this during admission |
| IV fluids | Normal saline or Ringer's lactate | If febrile and dehydrated; monitor urine output (AKI history) |
| Iron supplementation | Continue FST (Ferrous Sulphate Tablets) | Hb was 9.6 - continue as she was already prescribed |
| Continue antihypertensives | As per previous prescription | BCT (amlodipine?) + Ca supplement already on discharge |
| Blood pressure monitoring | At least twice daily | She has SHTN; sepsis can cause BP fluctuation |
| Sign | Concern |
|---|---|
| High fever >39°C with rigors | Bacteraemia / sepsis |
| Tachycardia + hypotension | Septic shock |
| Abdominal rigidity / rebound | Peritonitis |
| Watery or faeculent discharge | VVF or RVF |
| Rising creatinine | AKI recurrence - she is at risk |
| No improvement in 48 hrs on antibiotics | Abscess needing drainage |
| Priority | Action |
|---|---|
| 1 | Check vitals - assess for sepsis |
| 2 | Speculum examination - identify source of pus |
| 3 | HVS culture + wound swab |
| 4 | CBC, CRP, blood cultures, creatinine (AKI history) |
| 5 | Pelvic USG |
| 6 | Upgrade antibiotics: Cefotaxime IV + Metronidazole (if moderate-severe) OR Amoxiclav + Metronidazole oral (if mild) |
| 7 | Gynaecology consultation - vault assessment, haematoma drainage if needed |
| 8 | Continue FST, antihypertensives, paracetamol |
| 9 | Monitor renal function closely (prior AKI; avoid nephrotoxic drugs) |
| 10 | Admit if any red flag present |